Direct Rx 2022-03-09 Health serious FDA
Health · FDA · Recall #FDA-D-0637-2022
Moxifloxacin Ophthalmic Solution USP 0.5%, 3 mL, Packaged and Distributed By: Direct Rx… Recall
Issued March 9, 2022 · Direct Rx
In March 2022, Direct Rx recalled the Moxifloxacin Ophthalmic Solution USP 0.5%, 3 mL, Packaged and Distributed By: Direct Rx…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed impurities/degradation specifications
What you should do
- 1 Stop using Moxifloxacin Ophthalmic Solution USP 0.5%, 3 mL, Packaged and Distributed By: Direct Rx… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Direct Rx to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Direct Rx
- Category
- Health
- Recall date
- March 9, 2022
- Units affected
- Not reported
- Sold at
- Florida
- Recall number
- FDA-D-0637-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Direct Rx has 17 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.